Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : VVUS: VIVUS INC. (NASDAQ) -- Ignore unavailable to you. Want to Upgrade?

To: scope who wrote (18683)	2/12/1999 12:00:00 PM
From: Curt Whitaker	Respond to of 23519

By summer, this dog will be under one,anyway. Based on even a cursory look at VVUS financials, they will not go under $1. They are now profitable, and should remain so as more countries come online and a domestic partner is found. New drugs in the pipeline, and the MUSE applicator hold unique value of their own (for buyout valuation). Bottom line, VVUS is already trading below book value - going lower just makes the opportunity that much greater for those looking to average down. Curt